Advertisement

National and State-Specific Estimates of Settings of Receiving Human Papillomavirus Vaccination Among Adolescents in the United States

      Abstract

      Purpose

      Human papillomavirus (HPV) vaccination in the United States has been recommended for girls since 2006 and for boys since 2011. However, settings of receiving HPV vaccination have not been assessed. The purpose of this study is to assess settings of receiving HPV vaccination among adolescents in order to understand what strategies are needed to improve vaccination uptake.

      Methods

      Data from the 2018 National Immunization Survey–Teen (NIS–Teen) were analyzed to assess place of HPV vaccination overall, and by gender, quarter, and other selected variables among adolescents in the United States. The 2016–2018 NIS–Teen data were combined to assess state-specific place of HPV vaccination.

      Results

      Among vaccinated adolescents aged 13–17 years, a doctor's office was the most common place where HPV vaccination was received (79.2%), followed by clinics, health centers, or other medical facilities (13.5%), health department (4.1%), hospital or emergency room (2.3%), schools (.5%), and pharmacies or stores (.4%). Overall, 99.1% of adolescents aged 13–17 years received HPV vaccination at medical settings and only .9% at nonmedical settings. Reported vaccination in nonmedical settings by state ranged from less than .1% in Delaware, Florida, and New Hampshire to 4.1% in North Dakota, with a median of 1.0%.

      Conclusions

      Doctor's offices were the most common medical setting for adolescents to receive HPV vaccination. Less than 1% of adolescents received vaccination at nonmedical settings. Continuing work with medical and nonmedical settings to identify and implement appropriate strategies are needed to improve HPV vaccination coverage among adolescents.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Adolescent Health
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Satterwhite C.L.
        • Torrone E.
        • Meites E.
        • et al.
        Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008.
        Sex Transm Dis. 2013; 40: 187-193
        • Centers for Disease Control and Prevention (CDC)
        Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on immunization Practices (ACIP).
        MMWR. 2007; 56: 1-24
        • Centers for Disease Control and Prevention (CDC)
        Recommendations on the use of quadrivalent human papillomavirus vaccine in males — Advisory Committee on Immunization Practices (ACIP), 2011.
        MMWR. 2011; 60: 1705-1708
        • Petrosky E.
        • Bocchini J.A.
        • Hariri S.
        • et al.
        Use of 9-valent human papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of the Advisory Committee on immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2015; 64: 300-304
        • Meites E.
        • Kempe A.
        • Markowitz L.E.
        Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2016; 65: 1405-1408
        • Meites E.
        • Szilagyi P.G.
        • Chesson H.W.
        • et al.
        Human papillomavirus vaccination for adults: Updated recommendations of the Advisory Committee on immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2019; 68: 698-702
        • Centers for Disease Control and Prevention (CDC)
        National and state vaccination coverage among adolescents aged 13–17 years – United States, 2013.
        MMWR. 2014; 63: 625-633
        • Centers for Disease Control and Prevention (CDC)
        National and state vaccination coverage among adolescents aged 13–17 years – United States, 2015.
        MMWR. 2016; 65: 850-858
        • Centers for Disease Control and Prevention (CDC)
        National and state vaccination coverage among adolescents aged 13–17 years – United States, 2017.
        MMWR. 2018; 67: 909-917
        • Centers for Disease Control and Prevention (CDC)
        National and state vaccination coverage among adolescents aged 13–17 years – United States, 2018.
        MMWR. 2019; 68: 718-723
        • US Department of Health and Human Services
        Immunization and infectious diseases.
        (Available at:)
        • Stokley S.
        • Freed G.
        • et al.
        • National Vaccine Advisory Committee
        Adolescent vaccination: Recommendations from the national vaccine Advisory Committee.
        Am J Prev Med. 2009; 36: 278-279.e6
        • Centers for Disease Control and Prevention (CDC)
        Place of influenza vaccination among adults-United States, 2010–2011 influenza season.
        MMWR. 2011; 60: 781-785
        • Lu P.J.
        • O'Halloran A.
        • Ding H.
        • et al.
        National and state-specific estimates of place of influenza vaccination among adult populations –United States, 2011–12 influenza season.
        Vaccine. 2014; 32: 3198-3204
        • Centers for Disease Control and Prevention (CDC)
        National and state-level place of flu vaccination among vaccinated adults in the United States, 2014–15 Flu Season.
        (Available at:)
        • Santibanez T.A.
        • Vogt T.M.
        • Zhai Y.
        • McIntyre A.F.
        Place of influenza vaccination among children--United States, 2010–11 through 2013–14 influenza seasons.
        Vaccine. 2016; 34: 1296-1303
        • Centers for Disease Control and Prevention (CDC)
        National immunization survey–teen.
        (Available at:)
        • Centers for Disease Control and Prevention (CDC)
        National immunization survey–teen.
        (Available at:)
        • Centers for Disease Control and Prevention (CDC)
        Impact of a methodological change from a dual-frame landline and cell-phone sample design to a single-frame cell-phone sample design on vaccination coverage estimates among adolescents 13–17 years, Natl Immunization Survey–Teen, 2016–2017.
        (Available at:)
        • Moss J.L.
        • Reiter P.L.
        • Truong Y.K.
        • et al.
        School entry requirements and coverage of nontargeted adolescent vaccines.
        Pediatrics. 2016; 138: e20161414
        • Bernstein H.H.
        • Bocchini Jr., J.A.
        Practical Approaches to optimize adolescent immunization.
        pediatrics. 2017; 139: e20164187
        • Head K.J.
        • Biederman E.
        • Sturm L.A.
        • Zimet G.D.
        A retrospective and prospective look at strategies to increase adolescent HPV vaccine uptake in the United States.
        Hum Vaccin Immunother. 2018; 14: 1626-1635
      1. HPV resource center for pharmacists has information, practice tools, resources.
        (Available at:)
        • Dingman D.A.
        • Schmit C.D.
        Authority of pharmacists to administer human papillomavirus vaccine: Alignment of state laws with age-level recommendations.
        Public Health Rep. 2018; 133: 55-63
      2. Pharmacist administered vaccines: Types of vaccines authorized to administer.
        (Available at:)
      3. Encouraging immunization information system Use in Community pharmacy practice.
        (Available at:)
        • Calo W.A.
        • Gilkey M.B.
        • Shah P.
        • et al.
        Parents' willingness to get human papillomavirus vaccination for their adolescent children at a pharmacy.
        Prev Med. 2017; 99: 251-256
        • Shah P.D.
        • Calo W.A.
        • Marciniak M.W.
        • et al.
        Support for Pharmacist-Provided HPV vaccination: National surveys of U.S. Physicians and parents.
        Cancer Epidemiol Biomarkers Prev. 2018; 27: 970-978
        • Steyer T.E.
        • Ragucci K.R.
        • Pearson W.S.
        • Mainous A.G.
        The role of pharmacists in the delivery of influenza vaccinations.
        Vaccine. 2004; 22: 1001-1006
        • Centers for Disease Control and Prevention (CDC)
        Early-season flu vaccination coverage–United States, November 2018.
        (Available at:)
        • American Pharmacists Association
        Pharmacist administered vaccines: Influenza, age of administration authorized (2016, January).
        (Available at:)
        • Vanderpool R.C.
        • Breheny P.J.
        • Tiller P.A.
        • et al.
        Implementation and evaluation of a school-based human papillomavirus vaccination program in rural Kentucky.
        Am J Prev Med. 2015; 49: 317-323
        • Public Health England
        Human papillomavirus (HPV) vaccination coverage in adolescent females in England: 2015/2016.
        (Available at:)
        • Commonwealth Department of Human Services
        National HPV Vaccination Program Register HPV vaccination coverage by dose number (Australia) for females by age group in 2014.
        (Available at:)
        • Deuson R.R.
        • Hoekstra E.J.
        • Sedjo R.
        • et al.
        The Denver school-based adolescent hepatitis B vaccination program: A cost analysis with risk simulation.
        Am J Public Health. 1999; 89: 1722-1727
        • Cawley J.
        • Hull H.F.
        • Rousculp M.D.
        Strategies for implementing school-located influenza vaccination of children: A systematic literature review.
        J Sch Health. 2010; 80: 167-175
        • Nodulman J.A.
        • Starling R.
        • Kong A.S.
        • et al.
        Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs.
        J Sch Health. 2015; 85: 289-298
        • Heilly S.J.
        • Blade M.A.
        • Nichol K.L.
        Safety of influenza vaccinations administered in nontraditional settings.
        Vaccine. 2006; 24: 4024-4027
        • Bergus G.R.
        • Ernst M.E.
        • Sorofman B.A.
        Physician perceptions about administration of immunizations outside of physician offices.
        Prev Med. 2001; 32: 255-261
        • Ernst M.E.
        • Bergus G.R.
        • Sorofman B.A.
        Patients' acceptance of traditional and nontraditional immunization providers.
        J Am Pharm Assoc (Wash). 2001; 41: 53-59
        • Ventola C.L.
        Immunization in the United States: Recommendations, barriers, and Measures to improve compliance: Part 1: Childhood vaccinations.
        P T. 2016; 41: 426-436
        • Dorell C.
        • Yankey D.
        • Strasser S.
        Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: Teen, 2009.
        Clin Pediatr (Phila). 2011; 50: 1116-1124
      4. HPV vaccine mandates for elementary and secondary schools.
        (Available at:)
        https://www.immunize.org/laws/
        Date accessed: February 27, 2020
        • Moss J.L.
        • Reiter P.L.
        • Truong Y.K.
        • et al.
        School entry requirements and coverage of nontargeted adolescent vaccines.
        Pediatrics. 2016; 138: 1-12